Publication & Citation Trends
Most Cited Works
Publications
57 total
Body mass index as a predictive factor for efficacy of adjuvant taxane‐based chemotherapy in early‐stage breast cancer patients: A pooled analysis from adjuvant <scp>GEICAM</scp> Spanish Breast Cancer Group and <scp>TRIO</scp> Translational Research in Oncology Group studies PDF
Cited by 2
OpenAlex
Abstract P3-11-10: Benefit/risk relationship of TCH versus AC-TH in BCIRG 006: analysis using generalized pairwise comparisons
Cited by 0
Semantic Scholar
Abstract PO1-03-03: STEEP criteria v2.0 validation: A multi-trial analysis using GEICAM and TRIO adjuvant trials to evaluate surrogate endpoints for overall survival
Cited by 0
Semantic Scholar
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials PDF
Cited by 175
OpenAlex
Genetic polymorphisms and correlation with treatment induced cardiotoxicity and prognosis in breast cancer patients. OA
Cited by 5
Semantic Scholar
Abstract PD3-12: Central nervous system as first site of relapse in patients with HER2 positive early breast cancer treated in the BCIRG-006 trial
Cited by 2
OpenAlex
Abstract PD3-11:HER2/ERBB2status in “HER2equivocal” breast cancers by FISH and ASCO-CAP guidelines: False-positives due to heterozygous deletions of alternative control loci
Cited by 0
Semantic Scholar
Assessment of<i>ERBB2</i>/<i>HER2</i>Status in<i>HER2</i>-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines PDF
Cited by 35
OpenAlex
Research Topics
PI3K/AKT/mTOR signaling in cancer
(21)
HER2/EGFR in Cancer Research
(19)
Cancer Treatment and Pharmacology
(9)
Congenital Heart Disease Studies
(8)
Monoclonal and Polyclonal Antibodies Research
(8)
Frequent Co-Authors
Affiliations
Roche (Switzerland)
Universität Hamburg
University of California, Los Angeles
Pfizer (United States)
University of Milan